Gilboa Udi 13D/13G Filings for Nasus Pharma Ltd. (NSRX)

Gilboa Udi 13D and 13G filings for Nasus Pharma Ltd.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-11-10
5:05 pm
Purchase
2025-09-3013GNASUS PHARMA LTD
NSRX
Gilboa Udi1,901,311
21.100%
1,901,311increase
(New Position)
Filing